These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3083278

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA, Hagen T, Ottestad L, Jakobsen E.
    Tidsskr Nor Laegeforen; 1995 Nov 10; 115(27):3371-3. PubMed ID: 7491579
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of mitomycin-C-associated hemolytic uremic syndrome with plasmapheresis.
    Poch E, Almirall J, Nicolas JM, Torras A, Revert L.
    Nephron; 1990 Nov 10; 55(1):89-90. PubMed ID: 2112726
    [No Abstract] [Full Text] [Related]

  • 7. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE, Phillips TM, Schein PS.
    J Clin Oncol; 1985 May 10; 3(5):723-34. PubMed ID: 3923162
    [Abstract] [Full Text] [Related]

  • 8. First-line and salvage therapy of metastatic breast cancer with mitomycin/vinblastine.
    Sedlacek SM.
    Oncology; 1993 Apr 10; 50 Suppl 1():16-21. PubMed ID: 8483557
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pulmonary angiomatoid vascular changes in mitomycin C-associated hemolytic-uremic syndrome.
    Chang-Poon VY, Hwang WS, Wong A, Berry J, Klassen J, Poon MC.
    Arch Pathol Lab Med; 1985 Sep 10; 109(9):877-8. PubMed ID: 3927871
    [Abstract] [Full Text] [Related]

  • 11. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
    Cordonnier D, Vert-Pré FC, Bayle F, Alix JL, Couderc P.
    Nephrologie; 1985 Sep 10; 6(1):19-26. PubMed ID: 3923381
    [Abstract] [Full Text] [Related]

  • 12. Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
    Willie GR, Levy SM, Michaels RS, Zirkin RM.
    Henry Ford Hosp Med J; 1983 Sep 10; 31(2):104-9. PubMed ID: 6313552
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mitomycin C-induced pulmonary and renal toxicities.
    Loprinzi CL.
    Wis Med J; 1984 Mar 10; 83(3):16-7. PubMed ID: 6428065
    [No Abstract] [Full Text] [Related]

  • 20. Hemolytic-uremic syndrome associated with mitomycin therapy.
    Pavy MD, Wiley EL, Abeloff MD.
    Cancer Treat Rep; 1982 Mar 10; 66(3):457-61. PubMed ID: 7060035
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.